All In Biotech

Drug Trial Radar · NCT06544694

A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease

A Phase 3b Study to Investigate the Effect of 0.003% AR-15512 on the Ocular Surface Characteristics of Subjects With Dry Eye Disease

Last checked: Nov 20, 2026Latest source record: Mar 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

80

Actual

Start

Oct 8, 2024

Primary completion

Mar 21, 2025

Study completion Mar 21, 2025

Sponsor

Lead sponsor
Alcon ResearchIndustry
Sponsor type
Industry
First posted
Aug 9, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the effect of AR-15512 ophthalmic solution 0.003% (0.003% AR-15512) on ocular surface characteristics of subjects with dry eye disease (DED).

Conditions

  • Dry Eye Disease

Interventions

  • 0.003% AR-15512 ophthalmic solutionDrug

    Investigational ophthalmic solution administered via topical instillation

  • Artificial TearsOther

    Commercially available, preservative-free lubricant eye drops administered via topical instillation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Least Squares Mean Percentage Change From Baseline in Goblet Cell Density at Day 90 for 0.003% AR-15512Time frame: Day 1 pre-instillation (Baseline), Day 90 post instillation

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Butchertown Clinical Trials

    Louisville, Kentucky

  • Oculus Research

    Garner, North Carolina

  • Wilmington Eye

    Leland, North Carolina

  • CORE, Inc.

    Shelby, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.